PONATINIB AT A LOWER DOSE IS A GOOD OPTION IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS INTOLERANT TO PREVIOUS TKIS

EHA Library, Alessandra Iurlo, 294670

FAVORABLE OUTCOME IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA CO-EXPRESSING E13A2 AND E14A2 TRANSCRIPT TREATED FRONTLINE WITH NILOTINIB

EHA Library, Maria Pina Simula, 294672

SECOND GENERATION TYROSINE KINASE INHIBITORS IN THE FIRST-LINE CAN REDUCE TIME TO TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Oleg Shukhov, 294675

RETROSPECTIVE INDEPENDENT REVIEW OF ARTERIAL OCCLUSIVE EVENTS (AOES) IN THE PHASE 2 PACE TRIAL OF PONATINIB IN PHILADELPHIA CHROMOSOME POSITIVE (PH+) LEUKEMIA

EHA Library, James Januzzi, 294677

INDUCTION AND MAINTENANCE FOR CHRONIC MYELOID LEUKEMIA -CHRONIC PHASE: A NOVEL TREATMENT STRATEGY

EHA Library, Aditi Jain, 294681

THE REAL–LIFE STUDY EVALUATING THE EFFICACY AND SAFETY OF PONATINIB 'TOPASE' REVEALS INDUCTION OF DEEP MOLECULAR RESPONSES IN A COHORT OF 75 TKI-RESISTANT OR INTOLERANT PATIENTS WITH CML

EHA Library, Turhan Ali, 294683

LONG-TERM OUTCOMES OF TYROSINE KINASE INHIBITOR IN THIRD-LINE THERAPY OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Tamara Chitanava, 294685

CLINICAL IMPACTS OF GERMLINE AND SOMATIC DDX41 MUTATIONS ON MYELOID NEOPLASMS.

EHA Library, Hideki Makishima, 294686

IN VITRO AND IN VIVO PRECLINICAL MODELS FOR TESTING NEW THERAPIES FOR AZACITIDINE-RESISTANT MDS/AML.

EHA Library, Tomas Stopka, 294690

DISTINCT ETHNIC, CLINICAL, AND GENETIC CHARACTERISTICS OF DER(1;7) IN MYELODYSPLASTIC SYNDROMES.

EHA Library, Rurika Okuda, 294692

THE IMPACT OF MICROMEGAKARYOCYTES ON THE MYELODYSPLASTIC SYNDROMES PROGNOSIS

EHA Library, SILVIA SAUMELL, 294693

EFFECT OF LUSPATERCEPT (RAP-536) ON MDS PDX-MURINE MODELS WITH OR WITHOUT SF3B1 MUTATION

EHA Library, Mathieu Meunier, 294694

EVALUATING PATHOGENICITY OF RUNX1 VARIANTS OF UNCERTAIN SIGNIFICANCE BY APPLYING FUNCTIONAL ASSAYS ADDRESSING DIFFERENT MOLECULAR ASPECTS OF THE RUNX1:CBFΒ TRANSCRIPTION FACTOR COMPLEX

EHA Library, Tim Ripperger, 294695

LOW IGF1 SIGNALING IN MYELODYSPLASTIC CD34+ HSC IS ASSOCIATED WITH A LEUKEMIC STEM CELL SIGNATURE, REDUCED PROLIFERATIVE ACTIVITY AND POOR PROGNOSIS

EHA Library, Thomas Luft, 294697

KER-050, A NOVEL MODIFIED ACTRIIA LIGAND TRAP, INCREASES RED BLOOD CELL PRODUCTION IN CYNOMOLGUS MONKEYS

EHA Library, KEITH BABBS, 294699

IMPACT OF RAS-PATHWAY ACTIVATION ON PHENOTYPE AND OUTCOME IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA AND A TET2/SRSF2 COMUTATION

EHA Library, Klaus Geissler, 294700

TP53 STATUS AND OUTCOME IN MYELODYSPLASTIC SYNDROMES WITH COMPLEX ABERRANT KARYOTYPES

EHA Library, Detlef Haase, 294702

KER-050, A NOVEL INHIBITOR OF TGFΒ SUPERFAMILY SIGNALING, INDUCES RED BLOOD CELL PRODUCTION AND IS A POTENTIAL CANDIDATE FOR THE TREATMENT OF INEFFECTIVE HEMATOPOIESIS

EHA Library, Marina Feigenson, 294703

SEVERE ERYTHROID LINEAGE FAILURE DISCRIMINATES RESPONSE AND PROGNOSIS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Huijun Huang, 294704

ATYPICAL DELETIONS OF THE LONG ARM OF CHROMOSOME 5 WITH RETAINED COMMONLY DELETED REGIONS (CDR) IN MDS

EHA Library, Zuzana Zemanova, 294705

COMPARISON OF CLINICAL, GENETIC CHARACTERISTICS AND PROGNOSIS OF CMML WITH OR WITHOUT RING SIDEROBLASTS AND MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS WITH OR WITHOUT MONOCYTOSIS

EHA Library, Blanca Xicoy, 294708

DEFERASIROX-DEPENDENT IRON CHELATION AFFECTS MITOCHONDRIAL DYNAMICS AND STRUCTURE AND RESTORES TP53 FAMILY MEMBERS SIGNALING

EHA Library, Cristina Panuzzo, 294709

THE PROGNOSTIC IMPACT OF CYTOGENETIC SCORES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME TREATED WITH VENETOCLAX AND AZACITIDINE IN A PHASE 1 STUDY

EHA Library, Joshua Richter, 294712

ASSESSING THE DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Igor Stojkov, 294713

CLINICAL BENEFIT OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) AND HIGH TRANSFUSION BURDEN (HTB) IN THE PHASE 3 MEDALIST STUDY

EHA Library, Amer M. Zeidan, 294715

DIFFERENCES IN THE GENETIC LANDSCAPE BETWEEN YOUNGER AND OLDER PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Wan Hsuan Lee, 294716

COMPARISON BETWEEN UPFRONT TRANSPLANTATION AND CYTOREDUCTIVE THERAPY PRE-TRANSPLANTATION IN PATIENTS WITH MDS-EB-1 OR MDS-EB-2

EHA Library, Yili Chen, 294717

PROSPECTIVE EVALUATION FOR MYELOID CLONAL EVOLUTION AND ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CLONAL CYTOPENIAS OF UNDETERMINED SIGNIFICANCE (CCUS)

EHA Library, Marissa Li, 294722

ADMINISTRATION OF KER-050, A NOVEL ACTRIIA LIGAND TRAP, TO HEALTHY PARTICIPANTS ELICITED ROBUST AND SUSTAINED INCREASES IN HEMOGLOBIN AND PLATELETS

EHA Library, CLAUDIA ORDONEZ, 294723

DEVELOPMENT OF GUIDELINE-BASED INDICATORS FOR ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Nicolas Bonadies, 294725

ROLE AND RATE OF ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROMES: DATA FROM THE FISIM REGISTRY

EHA Library, Elena Crisà, 294727

LONGER-TERM RED BLOOD CELL (RBC) TRANSFUSION REDUCTION IN THE PHASE 3 MEDALIST STUDY OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) WITH RING SIDEROBLASTS (RS)

EHA Library, Rami S. Komrokji, 294730

PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY OF TIPIFARNIB IN CHRONIC MYELOMONOCYTIC LEUKEMIA, (CMML) AND OTHER MYELODYSPLASTIC /MYELOPROLIFERATIVE NEOPLASIAS (MDS/MPN).

EHA Library, Dr. Mrinal Patnaik, 294732

CONSENSUS SET OF CORE PATIENT-REPORTED OUTCOMES FOR MYELODYSPLASTIC SYNDROMES DEFINED BY PATIENTS AND HEMATOLOGISTS – EUMDS REGISTRY GROUP STUDY

EHA Library, Igor Stojkov, 294734

CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA WHO DEVELOPED THERAPY RELATED MYELOID NEOPLASMS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Fevzi Yalniz, 294735

AZACITIDINE AND LENALIDOMIDE (COMBINED VERSUS SEQUENTIAL TREATMENT) IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES. FINAL RESULTS OF A RANDOMIZED PHASE II MULTICENTER STUDY AND LONG-LASTING RESPONSES

EHA Library, Carlo Finelli, 294736

THE PROGNOSTIC IMPACT OF MEDULLARY ABNORMALITIES OF THE APPENDICULAR SKELETON DETECTED BY LOW-DOSE MULTIDETECTOR COMPUTED TOMOGRAPHY AND WILMS' TUMOR GENE 1 EXPRESSION LEVELS IN PATIENTS WITH MDS

EHA Library, Kentaro Narita, 294739

CLINICAL ANALYSIS OF GENE MUTATION CHARACTERISTICS AND MUTATION BURDEN IN MYELODYSPLASTIC SYNDROME

EHA Library, xiaodong lyu, 294740

EFFECT OF AZACYTIDINE ON SURVIVAL AND LEUKEMIA EVOLUTION IN INTERMEDIATE-RISK MDS: A RETROSPECTIVE COHORT ANALYSIS OF THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294741

NATURAL HISTORY OF LOWER-RISK MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS: A RETROSPECTIVE ANALYSIS OF THE CANADIAN MDS-CAN REGISTRY

EHA Library, Heather Leitch, 294742

MUTATIONS IN RAS PATHWAY GENES CORRELATE WITH TYPE OF FAILURE TO AZACITIDINE: GENOMIC ANALYSIS AT RANDOMIZATION ONTO THE INSPIRE TRIAL

EHA Library, Koichi Takahashi, 294746

CIRCULATING CONCENTRATIONS OF HMGB1 IN PATIENTS WITH MYELODYSPLASTIC SYNDROME: EXPLORATORY STUDY

EHA Library, Elia Apodaca, 294747

A THREE-PARAMETER SCORE BASED ON BONE MARROW IMMUNOPHENOTYPING IS COMPLEMENTARY TO IPSS-R FOR PROGNOSIS OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Irene Lorand-Metze, 294750

INTERIM RESULTS FROM AN ONGOING PHASE 1/2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401), A CD123-DIRECTED THERAPY, IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

EHA Library, Mrinal M. Patnaik, 294753

A ZEBRAFISH MODEL FOR SEVERE CONGENITAL NEUTROPENIA WITH HAX1 DEFICIENCY

EHA Library, Narges Aghaallaei, 294758

LONG NON-CODING RNA FAM157C CONTRIBUTED TO THE PROLIFERATION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONES

EHA Library, Rong Fu, 294759

PHENOTYPIC CHANGES CAUSED BY NOVEL SNV OF RPS7 GENE

EHA Library, AGATA KUBICKOVA, 294760

CELLULAR AND MOLECULAR MECHANISMS UNDERLYING THE ALTERED IN VITRO CAPILLARY-LIKE CAPABILITY OF SHWACHMAN-DIAMOND SYNDROME MESENCHYMAL STROMAL CELLS

EHA Library, Gloria Bedini, 294761

WHOLE GENOME SEQUENCING REVEALS BROAD DIAGNOSTIC HETEROGENEITY IN PATIENTS WITH FEATURES RESEMBLING DIAMOND-BLACKFAN ANAEMIA

EHA Library, Josu de la Fuente, 294763

LANDSCAPE OF GENETIC VARIATIONS IN A COHORT OF CHILDREN WITH BONE MARROW FAILURE (BMF) USING A TARGETED NEXT GENERATION SEQUENCING (NGS) APPROACH

EHA Library, Prashant Chhabra, 294764

STROMAL PRECURSORS IN THE BONE MARROW OF UNTREATED APLASTIC ANEMIA PATIENTS

EHA Library, Alena Dorofeeva, 294765

THE ROLE OF LNCRNA-AF117829.1 IN THE IMMUNOPATHOGENESIS OF CD8+ T CELLS IN PATIENTS WITH SEVERE APLASTIC ANEMIA

EHA Library, Rong Fu, 294767

EFFECTIVENESS OF ECULIZUMAB TREATMENT IN PATIENTS AGED ≥ 65 YEARS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM THE INTERNATIONAL PNH REGISTRY

EHA Library, Jong Wook Lee, 294770

EFFICACY AND SAFETY OF NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS WHO RELAPSED AFTER DISCONTINUATION OF IMATINIB FOR TREATMENT-FREE REMISSION: RESULTS OF THE FRENCH NILO POST-STIM STUDY

EHA Library, Dulucq Stephanie, 294669

LONG-TERM FOLLOW UP OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS WITH CLONAL CHROMOSOMAL ABERRATIONS IN PHILADELPHIA NEGATIVE CELLS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Christoph Varelas, 294671

IS BCR-ABL1 TRANSCRIPT A RELIABLE MARKER AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT)? LONG-TERM FOLLOW-UP OF CML ALLOTRANSPLANTED PATIENTS WITH BCR/ABL1 FLUCTUATIONS

EHA Library, Antonella Antonella Bruzzese, 294673

DASATINIB IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND SUBOPTIMAL RESPONSES TO 3 MONTHS OF IMATINIB THERAPY: 3-YEAR EXTENDED FOLLOW-UP (FU) FROM DASCERN

EHA Library, Jorge Cortes, 294674

TARGETING DIPEPTIDYLPEPTIDASE IV (CD26) FOR A SECOND TKI DISCONTINUATION ATTEMPT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DESIGN AND PHASE 1 RESULTS OF THE DOLPHIN-STAR STUDY.

EHA Library, Camille C.B. Kockerols, 294676

IMATINIB CORRECTS IMMUNE EXHAUSTION OF CYTOTOXIC T-LYMPHOCYTES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Fen Saj, 294678

DETERMINANTS OF FIRST-LINE THERAPY CHOICE IN CHRONIC PHASE CML: A REAL-LIFE SURVEY IN ITALY

EHA Library, Mario Tiribelli, 294679

NEXT GENERATION SEQUENCING IDENTIFIES COMMON MUTATIONAL SIGNATURES IN NOVEL GENES REPRESENTING DIFFERENT BIOLOGICAL PATHWAYS ASSOCIATED WITH ACUTE TRANSFORMATION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Zafar Iqbal, 294680

A CROSS TALK BETWEEN TREATMENT FREE REMISSION AND CML POPULATION AGING

EHA Library, Marc Delord, 294682

BOSUTINIB FOR CHRONIC PHASE CHRONIC MYELOID LEUKEMIA AFTER IMATINIB FAILURE: ≥8-YEAR UPDATE OF A PHASE 1/2 STUDY

EHA Library, Jorge Cortes, 294684

MODULATION OF THE IL-6/STAT3 SIGNALING AXIS IN CD4+ T CELLS REPRESENTS A IMMUNE-MEDIATED MECHANISM OF ACTION OF AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Ioannis Kotsianidis, 294687

LOSS OF INTRON RETENTION INDUCES LOSS OF R-LOOPS AND REPLICATION STRESS IN SF3B1-MUTATED ERYTHROBLASTS

EHA Library, Carine Lefèvre, 294688

KINETIC PROFILING IDENTIFIES AGE- AND MDS- RELATED CHANGES IN HEMATOPOIETIC STEM AND PROGENITOR CELL DYNAMICS

EHA Library, Michele Buck, 294691

PROMOTER CHROMATIN STATE TRANSITIONS AND TRANSCRIPTIONAL ACTIVITY IN ASXL1-MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Moritz Binder, 294696

INHIBITION OF GLYCOLYSIS IN MYELODYSPLASTIC SYNDROME (MDS): A NOVEL STRATEGY FOR NEW APPROACH FOR THE TARGETED THERAPY OF MDS

EHA Library, Seiichi Okabe, 294698

UPREGULATED HIF-1Α EXPRESSION IN HIGH RISK MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA PATIENTS IS ASSOCIATED WITH BETTER RESPONSE TO AZACITIDINE - DATA FROM THE HELLENIC MDS STUDY GROUP

EHA Library, Vasiliki Pappa, 294701

BIOENERGETIC ALTERATIONS AS DEFINING FEATURES OF LOW VERSUS HIGH RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Aikaterini Poulaki, 294706

CD3+CD56+ CELLS (TR3-56) AND IMMUNE TOLERANCE CONTROL IN THE BONE MARROW (BM) OF MYELODYSPLASTYC SYNDROME (MDS) INDIVIDUALS.

EHA Library, Stefania Leone, 294707

DNA REPAIR MECHANISMS IN MYELODYSPLASTIC SYNDROMES (MDS): DIFFERENTIAL GENE EXPRESSION IN MDS SUBTYPES

EHA Library, Stamatina Roussou, 294710

MOLECULAR CHARACTERISTICS THAT PREDICT RESPONSE TO AZACITIDINE THERAPY

EHA Library, Yasuhito Nannya, 294711

MOLECULAR AND CLINICAL FEATURES OF MYELOID NEOPLASMS WITH SOMATIC DDX41 MUTATIONS

EHA Library, Zhijian Xiao, 294714

COMBINING FLOW CYTOMETRY, CYTOGENETICS AND MUTATION PROFILING IN PATIENTS WITH IDIOPATHIC CYTOPENIA: AN INTEGRATED PREDICTIVE MODEL

EHA Library, Aref Al-Kali, 294718

REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS IN THE US: A SEER-MEDICARE ANALYSIS

EHA Library, Eytan M. Stein, 294719

EVOLUTIONARY ACTION SCORE OF MISSENSE TP53 MUTATIONS (EAP53) IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN MYELODYSPLASTIC SYNDROMES

EHA Library, Rashmi Kanagal-Shamanna, 294720

PROGNOSTIC VALUE OF MONOCYTE SUBSET DISTRIBUTION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) : RESULTS OF A MULTICENTER STUDY.

EHA Library, Matthieu Jestin, 294721

EFFECTS OF LUSPATERCEPT ON SERUM FERRITIN IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) WITH RING SIDEROBLASTS (RS) IN THE PHASE 3 MEDALIST TRIAL

EHA Library, Pierre Fenaux, 294724

MOLECULAR BASIS AND CLINICAL IMPLICATION OF SPONTANEOUS IN VITRO MYELOID COLONY FORMATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Klaus Geissler, 294726

PRACINOSTAT LOWER DOSE PLUS AZACITIDINE SAFETY AND EFFICACY IN PATIENTS WITH HIGH/VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES: A PHASE II STUDY

EHA Library, Michael K. Keng, 294728

ASSESSMENT OF DOSE-DEPENDENT RESPONSE TO LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) WITH RING SIDEROBLASTS IN THE PHASE 3 MEDALIST TRIAL

EHA Library, Uwe Platzbecker, 294729

SIGNIFICANT RATE OF PATIENTS WITH MYELODYSPLASTIC SYNDROME FAILING TO REACH ALLOGENIC STEM CELL TRANSPLANTATION: A POPULATION -BASED STUDY

EHA Library, Carolin Lindholm, 294731

IMPACT OF ERYTHROPOIETIN STIMULATION AGENTS AND RED BLOOD CELL TRANSFUSION ON HEALTH-RELATED QUALITY OF LIFE IN LOWER-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Hege Gravdahl Garelius, 294733

FACTORS ASSOCIATED WITH RISK OF CARDIOVASCULAR DEATH IN MDS. A NESTED CASE CONTROL STUDY OF 831 PATIENTS OF THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294737

CUMULATIVE LINES OF PRIOR CHEMOTHERAPY PREDICT OVERALL SURVIVAL IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Urshila Durani, 294738

IVOSIDENIB (IVO) IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME (R/R MDS): UPDATED ENROLLMENT OF A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

EHA Library, Courtney D DiNardo, 294743

THE BURDEN OF RED BLOOD CELL TRANSFUSIONS ON OVERALL SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND QUALITY OF LIFE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES AND RING SIDEROBLASTS

EHA Library, Heather Leitch, 294744

POST-TRANSPLANT OUTCOMES OF PATIENTS WITH MDS AND AML AFTER RECEIVING HYPOMETHYLATING AGENT THERAPY COMBINED WITH THE TIM-3 INHIBITOR, MBG453

EHA Library, Andrew Brunner, 294745

MDS IRON ROAD: AN INTERNET-BASED ALGORITHM FOR THE DIAGNOSIS, WORKUP AND MANAGEMENT OF IRON OVERLOAD (IOL) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) FROM THE CANADIAN CONSORTIUM ON MDS (CCMDS)

EHA Library, Heather Leitch, 294748

ESTIMATED GLOMERULAR FILTRATION RATE INDEPENDENTLY PREDICTS OUTCOME OF AZACYTIDINE THERAPY IN MDS. RESULTS FROM THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294749

TRANSFORMATION FROM MYELODYSPLASTIC SYNDROME AND RESEMBLES, IDIOPATHIC CYTOPENIA AND CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, TO ACUTE MYELOID LEUKEMIA.

EHA Library, Volkan Bas, 294751

A RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE EFFECTS OF PEVONEDISTAT ON THE QTC INTERVAL IN PATIENTS WITH ADVANCED MALIGNANCIES

EHA Library, Xiaofei Zhou, 294752

DIACYLGLYCEROL KINASE Z DEFICIENCY TRIGGERS EARLY SIGNS OF APLASTIC ANEMIA IN MICE

EHA Library, Miguel Martin Salgado, 294754

UM171 STIMUALTES THE HEMATOPOIETIC DIFFERENTIATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS OF PATIENTS WITH APLASTIC ANEMIA

EHA Library, Maria Florencia Tellechea, 294755

STUDY OF MOLECULAR, FLOW-CYTOMETRIC CHARACTERISTICS AND LONG-TERM OUTCOME OF PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND ISOLATED NEUTROPENIA (ICUS-N)

EHA Library, Stavros Papadakis, 294756

THE ROLE OF DECREASED TIM3 EXPRESSION OF NK CELLS IN THE IMMUNE PATHOGENESIS OF SEVERE APLASTIC ANEMIA

EHA Library, Shaoxue Ding, 294757

DEVELOPMENT OF A COMPOSITE ENDPOINT TO EVALUATE TREATMENT BENEFIT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Austin Kulasekararaj, 294762

OUTCOMES OF PATIENTS WITH MONOSOMY 7 EVOLVED FROM SEVERE APLASTIC ANEMIA: TRANSPLANT VERSUS CHEMOTHERAPY AND SUPPORTIVE CARE

EHA Library, Emma Groarke, 294768

ORAL CXCR4 ANTAGONIST MAVORIXAFOR TREATMENT IN PATIENTS WITH WHIM SYNDROME: RESULTS OF AN OPEN LABEL PHASE 2 STUDY WITH LONG-TERM EXTENSION.

EHA Library, Sarah Cohen, 294769